Observational analysis shows HIV testing rates at 17% among adolescents in Ekurhuleni, indicating significant gender differences in treatment outcomes.
We investigated the progress towards the second and third 95-95-95 UNAIDS targets among adolescents and young adults (AYA) living with HIV in the Ekurhuleni district, South Africa. A total of 39,038 AYA were tested for HIV in 2018, 17.0% (95% CI: 16.6%-17.4%) tested positive, 79.5% (95% CI: 78.5%-80.5%) were aged 20-24, and the majority were females 86.8% (95% CI: 86.0%-87.6%) and of these females 33.8% (95% CI: 32.6%-35.1%) were pregnant. Antiretroviral therapy (ART) initiation rate was 81.9% (95% CI: 81.0%-82.9%) and 63% were initiated on the same day. Viral load suppression had an upward trajectory of 63%, 66%, 71%, 73%, 81%, while retention rate regressed from 67%, 63%, 62%, 60%, 56% over 12, 24, 36, 48 and 60 months. Compared to males, females achieved greater proportions while when comparing the three-age bands, AYA aged 20-24 achieved better outcomes than AYA aged 10-14 and 15-19. These findings underscore the importance of interventions focused on targeted testing and diagnosis, linkage to treatment, retention to care and viral load suppression of younger adolescents (10-14 years) and male AYA and implementation of age and gender disaggregated HIV cascade indicators tracking for this subpopulation.
No takes yet. Share an insight, caveat, or question.
Silinda et al. (2025) studied this question.